These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29373841)

  • 41. Synthetic SiRNA Delivery: Progress and Prospects.
    Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
    Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smart drug delivery nanocarriers with self-assembled DNA nanostructures.
    Li J; Fan C; Pei H; Shi J; Huang Q
    Adv Mater; 2013 Aug; 25(32):4386-96. PubMed ID: 23765613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
    Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
    Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers.
    Zheng W; Yin T; Chen Q; Qin X; Huang X; Zhao S; Xu T; Chen L; Liu J
    Acta Biomater; 2016 Feb; 31():197-210. PubMed ID: 26612416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. siRNA delivery using nanocarriers - an efficient tool for gene silencing.
    Khurana B; Goyal AK; Budhiraja A; Arora D; Vyas SP
    Curr Gene Ther; 2010 Apr; 10(2):139-55. PubMed ID: 20353386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ideal and Reality: Barricade in the Delivery of Small Interfering RNA for Cancer Therapy.
    Wu D; Han H; Xing Z; Zhang J; Li L; Shi W; Li Q
    Curr Pharm Biotechnol; 2016; 17(3):237-47. PubMed ID: 26511977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders.
    Maheshwari R; Tekade M; Sharma PA; Tekade RK
    Curr Pharm Des; 2015; 21(30):4427-40. PubMed ID: 26471319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current advancements in self-assembling nanocarriers-based siRNA delivery for cancer therapy.
    Kandasamy G; Maity D
    Colloids Surf B Biointerfaces; 2023 Jan; 221():113002. PubMed ID: 36370645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic nanocarriers for the delivery of polynucleotides to the eye.
    Saraiva SM; Castro-López V; Pañeda C; Alonso MJ
    Eur J Pharm Sci; 2017 May; 103():5-18. PubMed ID: 28263915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy.
    Ashrafizadeh M; Zarrabi A; Hushmandi K; Hashemi F; Rahmani Moghadam E; Raei M; Kalantari M; Tavakol S; Mohammadinejad R; Najafi M; Tay FR; Makvandi P
    ACS Comb Sci; 2020 Dec; 22(12):669-700. PubMed ID: 33095554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand-Installed Nanocarriers toward Precision Therapy.
    Mi P; Cabral H; Kataoka K
    Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction in the size of layered double hydroxide nanoparticles enhances the efficiency of siRNA delivery.
    Chen M; Cooper HM; Zhou JZ; Bartlett PF; Xu ZP
    J Colloid Interface Sci; 2013 Jan; 390(1):275-81. PubMed ID: 23084868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Micelle-like nanoparticles as carriers for DNA and siRNA.
    Navarro G; Pan J; Torchilin VP
    Mol Pharm; 2015 Feb; 12(2):301-13. PubMed ID: 25557580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?
    Aigner A; Kögel D
    Nanomedicine (Lond); 2018 Jan; 13(1):89-103. PubMed ID: 29199893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic siRNA delivery using biocompatible calcium phosphate nanoparticles.
    Park K
    J Control Release; 2010 Mar; 142(3):295. PubMed ID: 20149829
    [No Abstract]   [Full Text] [Related]  

  • 60. SiRNA delivery: challenges and role of carrier systems.
    Shegokar R; Al Shaal L; Mishra PR
    Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.